GENERICSKING TRADING

To be considered bioequivalent to its innovative counterpart, a generic drug must not only have the same active pharmaceutical ingredient, but the rate and extent of absorption of its active ingredient into the bloodstream must also be the same or similar, within ranges designated and approved by the relevant regulatory health authority. (Most oral medications must be absorbed into the bloodstream before they can produce the medical results your physician is trying to achieve). If the regulatory authority is satisfied with the tests submitted by the manufacturers for its review, the authority rates the generic drug as bioequivalent to the brand, which means that the generic version is acknowledged as having the same therapeutic effect as the innovative drug.

Also known as: Genericsking Trading Inc.